Cargando…

Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent

We recently used CRISPRi/a-based chemical-genetic screens and cell biological, biochemical, and structural assays to determine that rigosertib, an anti-cancer agent in phase III clinical trials, kills cancer cells by destabilizing microtubules. Reddy and co-workers (Baker et al., 2020, this issue of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jost, Marco, Chen, Yuwen, Gilbert, Luke A., Horlbeck, Max A., Krenning, Lenno, Menchon, Grégory, Rai, Ankit, Cho, Min Y., Stern, Jacob J., Prota, Andrea E., Kampmann, Martin, Akhmanova, Anna, Steinmetz, Michel O., Tanenbaum, Marvin E., Weissman, Jonathan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332992/ https://www.ncbi.nlm.nih.gov/pubmed/32619469 http://dx.doi.org/10.1016/j.molcel.2020.06.008

Ejemplares similares

Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent
por: Jost, Marco, et al.
Publicado: (2017)

Time-resolved single-cell sequencing identifies multiple waves of mRNA decay during the mitosis-to-G1 phase transition
por: Krenning, Lenno, et al.
Publicado: (2022)

Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics
por: Waight, Andrew B., et al.
Publicado: (2016)

Microtubule binding by KNL-1 contributes to spindle checkpoint silencing at the kinetochore
por: Espeut, Julien, et al.
Publicado: (2012)

Rigosertib and Cholangiocarcinoma: A Cell Cycle Affair
por: Malacrida, Alessio, et al.
Publicado: (2021)

Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure
por: Dohle, Wolfgang, et al.
Publicado: (2019)

Anti-tumor effects of rigosertib in high-risk neuroblastoma
por: Radke, Katarzyna, et al.
Publicado: (2021)

Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent
por: Malacrida, Alessio, et al.
Publicado: (2023)

Kinesin-4 KIF21B is a potent microtubule pausing factor
por: van Riel, Wilhelmina E, et al.
Publicado: (2017)

High-content imaging-based pooled CRISPR screens in mammalian cells
por: Yan, Xiaowei, et al.
Publicado: (2021)

Actin–microtubule coordination at growing microtubule ends
por: López, Magdalena Preciado, et al.
Publicado: (2014)

Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin
por: Sharma, Ashwani, et al.
Publicado: (2017)

Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)
por: Monfort-Vengut, Ana, et al.
Publicado: (2023)

Ectopic A-lattice seams destabilize microtubules
por: Katsuki, Miho, et al.
Publicado: (2014)

TBA-7 is not a microtubule-destabilizing tubulin
por: Lu, Yu-Ming, et al.
Publicado: (2021)

Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia
por: Baker, Stacey J., et al.
Publicado: (2019)

Photoswitchable Epothilone‐Based Microtubule Stabilisers Allow GFP‐Imaging‐Compatible, Optical Control over the Microtubule Cytoskeleton
por: Gao, Li, et al.
Publicado: (2022)

CLASP Suppresses Microtubule Catastrophes through a Single TOG Domain
por: Aher, Amol, et al.
Publicado: (2018)

Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
por: Wang, Yin, et al.
Publicado: (2021)

In Vitro Evaluation of Rigosertib Antitumoral and Radiosensitizing Effects against Human Cholangiocarcinoma Cells
por: Malacrida, Alessio, et al.
Publicado: (2021)

Microtubule dissassembly in vivo: intercalary destabilization and breakdown of microtubules in the heliozoan Actinocoryne contractilis
Publicado: (1992)

Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
por: Rawat, Vipin, et al.
Publicado: (2023)

Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy
por: González, Myriam, et al.
Publicado: (2021)

Localized Aurora B activity spatially controls non-kinetochore microtubules during spindle assembly
por: Tanenbaum, Marvin E., et al.
Publicado: (2011)

Regulation of mRNA translation during mitosis
por: Tanenbaum, Marvin E, et al.
Publicado: (2015)

Structural determinants of microtubule minus end preference in CAMSAP CKK domains
por: Atherton, Joseph, et al.
Publicado: (2019)

Importin α/β promote Kif18B microtubule association and enhance microtubule destabilization activity
por: Shrestha, Sanjay, et al.
Publicado: (2023)

Lattice defects induced by microtubule-stabilizing agents exert a long-range effect on microtubule growth by promoting catastrophes
por: Rai, Ankit, et al.
Publicado: (2021)

LKB1 Destabilizes Microtubules in Myoblasts and Contributes to Myoblast Differentiation
por: Mian, Isma, et al.
Publicado: (2012)

Synthesis and antitumor effects of novel benzyl naphthyl sulfoxide/sulfone derivatives derived from Rigosertib
por: Tang, Lin, et al.
Publicado: (2021)

Factor quinolinone inhibitors alter cell morphology and motility by destabilizing interphase microtubules
por: Stoiber, Patrick, et al.
Publicado: (2021)

Cytoplasmic dynein crosslinks and slides anti-parallel microtubules using its two motor domains
por: Tanenbaum, Marvin E, et al.
Publicado: (2013)

Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts
por: Cartelli, Daniele, et al.
Publicado: (2012)

Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule
por: Yang, Jianhong, et al.
Publicado: (2016)

HILI destabilizes microtubules by suppressing phosphorylation and Gigaxonin-mediated degradation of TBCB
por: Tan, Hao, et al.
Publicado: (2017)

Linking cortical microtubule attachment and exocytosis
por: Noordstra, Ivar, et al.
Publicado: (2017)

Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation
por: Günther, Julia K., et al.
Publicado: (2020)

Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
por: Zhou, Xinyi, et al.
Publicado: (2022)

SLAIN2 links microtubule plus end–tracking proteins and controls microtubule growth in interphase
por: van der Vaart, Babet, et al.
Publicado: (2011)

Structural basis of katanin p60:p80 complex formation
por: Rezabkova, Lenka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v688ffeqa6qh938ka7seh2kc9t